Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.’s Net Profit Dropped 18.5% in First Three Quarters of 2023

Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (浙江我武生物科技股份有限公司) (300357.SZ) reported a net profit of 259.8 million yuan in the first three quarters of 2023, down 18.5% year-on-year.

Meanwhile, the company posted 673.8 million yuan in revenue, down 3.8% year-on-year.

At the end of the reporting period, it had 2.5 billion yuan in total assets and 242.8 million yuan in total liabilities, with a liability-to-asset ratio of 9.7%.